's recently released statement, Pall
claims "the Minnesota jury was prevented, for procedural reasons, from seeing independent comparative data and other testimony" and further claims "had the jury been fully informed, the outcome of the case would have been different.
Corporation is the global leader in the rapidly growing field of filtration, separation and purification.
A pattern of evidence derived from studies of patients and animal models suggests that the elevated nitric oxide/peroxynitrite theory can be extended to MCS, FM, and PTSD (Pall
and Satterlee 2001).
This call will be webcast and can be accessed at Pall
Corporation's web site at www.
won the contract after Minneapolis Water Works completed extensive performance testing of competing ultrafiltration membrane pilot scale systems in June.
has chosen to provide this information to facilitate meaningful comparisons of past, present and future operating results and as a means to emphasize the results of ongoing operations.
Since the availability of the Pall
eBDS for detection of bacteria in platelets, there has been interest in applying the same technology to improve safety of red blood cells.
introduces two new membrane technology platforms to meet the increasing demands of single wafer and batch wet chemical processing.
This is a welcome and important addition to our toolbox," said Lisa McDermott, chief financial officer and treasurer for Pall
Moschella, who has over 17 years experience in accounting and finance, came to Pall
from the General Electric Company, where he served since 2002, most recently as Americas Region Controller for GE Water & Process Technologies.
BioSepra(R) PPA and HEA HyperCel(TM) mixed-mode sorbents equip process chromatographers with entirely new chemistries and new separation options for purifying proteins for higher yield and recovery under selected conditions.
Director, R&D Cell Therapy, Pall
Life Sciences, presented data comparing the Pall
Filter Harvest System to a traditional open-system, density gradient, centrifuge-based method for isolation of mononuclear cells (MNC) from whole blood.
NASDAQ: VIAC) and Pall
Corporation (NYSE: PLL) announced today the first U.
Nasdaq:ENTG) filed a lawsuit today against Pall
Corporation (NYSE:PLL) in the United States District Court for the District of Massachusetts.
Corporation (NYSE: PLL) introduces six new technologies at INTERPHEX2006 aimed at helping this converging marketplace bridge the gap between R&D and full-scale production.